docturnal
TimBre™ - Non-invasive, real-time point of care screening for infectious lung ailments leveraging cough Acoustics & AI
India
4 employees
Seed
Total: $1.00M
Biotechnology, Health Care
General Information
India
BounceWatch is an independent company data service, not affiliated with docturnal. To contact docturnal, visit docturnal.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does docturnal compare?
A PDF of docturnal and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting docturnal soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
India Market
Biotechnology
About docturnal
Business keywords: MedTech, Point of Care, Non-Invasive Screening, Pulmonary Tuberculosis, Pneumonia, COVID-19, Acoustics, Diagnostics, COPD, Asthma, Pediatric TB, Microphone Arrays
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Undisclosed | 4 |
|
25 Sep 2018 |
| Seed Round | Undisclosed | 1 |
|
03 Aug 2017 |
| Seed Round | INR1.00M | 2 |
|
30 Jan 2017 |
docturnal Alternatives & Competitors
View All Alternatives
Diagnostics Reimagined | Rapid Breath Tests for Disease Detection | Covid-19, Lung Cancer and more
Biosense is among the leading Point of Care Testing and Instrumentation companies in India.
Practice-changing, non-invasive cardiovascular and pulmonary devices.
FAQ About docturnal
Source: BounceWatch company record for docturnal, https://bouncewatch.com/company/docturnal, updated 30 December 2024. When citing, please name BounceWatch and link this page.
